NCT03820882 is a NA clinical trial of Catfish in Acute Ischemic Stroke, sponsored by Ministry of Science and Technology of the People´s Republic of China.

Who is sponsoring NCT03820882?

NCT03820882 is sponsored by Ministry of Science and Technology of the People´s Republic of China.

What drugs are being tested in NCT03820882?

Interventions in NCT03820882: Catfish, Solitaire FR.

What condition does NCT03820882 study?

NCT03820882 studies Acute Ischemic Stroke.

Is NCT03820882 still recruiting?

NCT03820882 is currently completed. Last updated 27 September 2022.

Last reviewed 2022-09-27 · How we verify

NCT03820882

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stent Retriever for Thrombectomy Revascularisation of Large Vessel Occlusions in Acute Ischemic Stroke(Catfish)

Completed NA Last updated 27 September 2022

What this trial tests

NA trial testing Catfish in Acute Ischemic Stroke in 238 participants. Completed in 5 June 2021.

Timeline

3 March 2019

Primary endpoint
5 January 2021

5 June 2021

Quick facts

Lead sponsor	Ministry of Science and Technology of the People´s Republic of China
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	238
Start date	3 March 2019
Primary completion	5 January 2021
Estimated completion	5 June 2021
Sites	1 location across China

Drugs / interventions tested

Catfish
Solitaire FR

Conditions studied

Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →

Sponsor

Ministry of Science and Technology of the People´s Republic of China

Who can join

Adults 18 to 80, any sex, with Acute Ischemic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a randomized, prospective, parallel-group, multicenter, open-label, non-inferiority trial. Patients are randomized 1 : 1 to either stent retriever(Catfish) or Solitaire for endovascular therapy for acute ischemic stroke. The study aims to evaluate the benefit and safety of stent retriever(Catfish) for acute ischemic stroke therapy, as compared to Solitaire FR.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled study.
Luo G, Yan X, Xiao G, Wei L, et al · · 2023 · cited 1× · PMID 37045544 · DOI 10.1136/svn-2022-002036

Verify or expand the search:

Other recruiting trials for Acute Ischemic Stroke

Currently open trials in the same condition.

NCT07115940 — Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours · NA · recruiting
NCT07404852 — Non-invasive Vagus Nerve Stimulation to Reduce Inflammation and Brain Injury Blood Biomarkers Following an Acute Ischemi · NA · recruiting
NCT07361302 — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe · Phase 3 · recruiting
NCT07436156 — SUMMIT RISE Study of Acute Ischemic Stroke Patients · Phase 4 · recruiting
NCT07203625 — Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours · Phase 4 · recruiting

Other Ministry of Science and Technology of the People´s Republic of China trials

Trials by the same sponsor.

NCT06730243 — Retzius-sparing Robot-assisted Radical Prostatectomy With "Sandwich" Technique of Total Urethral Reconstruction Versus S · NA · recruiting
NCT03844594 — Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH) · Phase 3 · unknown
NCT03753061 — Intracranial Thrombosis Aspiration Catheter for Recanalization in Acute Ischemic Stroke Therapy (RECOVER) · NA · unknown
NCT04051567 — Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies · Phase 4 · unknown
NCT04775836 — An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03820882 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ministry of Science and Technology of the People´s Republic of China
Last refreshed: 27 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03820882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing